| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |